Neoadjuvant therapy in melanoma with Georgina Long | 45 min
1391
students
0
Free
In this interview from Oncology News Australia, MIA’s Prof Georgina Long AO speaks with Prof Hans Prenen on a recent publication in Nature Medicine...
Free
Multidisciplinary management of SCC and BCC | 46 min
1460
students
0
Free
Squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) are the most common forms of non-melanoma skin cancers. They have a wide clinical and...
Free
Update on Merkel cell carcinoma pathology | 11 min
1460
students
0
Free
Merkel cell carcinoma is a rare but highly aggressive neuroendocrine tumour of the skin. Early diagnosis and timely intervention are essential for improving health...
Free
The complexities of adjuvant therapy in melanoma | 33 min
1540
students
0
Free
The success of immunotherapy and targeted therapy in the treatment of advanced melanoma has led to the same therapies being used in the adjuvant...
Free
Post-melanoma checks: Who, what and how often? | 16 min
1629
students
1
Free
Patients require long-term surveillance after receiving melanoma treatment. Definitive evidence-based guidelines for follow-up are lacking, but sensible guidelines based on an individual patient’s risk...
Free
Update on melanoma staging | 18 min
1629
students
0
Free
Accurate staging of patients with newly diagnosed melanomas is of great importance to obtain accurate estimates of prognosis and determine the most appropriate treatment...
Free
Systemic therapy updates in advanced melanoma | 60 min
1658
students
0
Free
Medical oncology has changed the way melanoma is treated and continues to evolve. In this webinar, Medical Oncologist A/Prof Matteo Carlino provides an updated...
Free
ESMO 2020: Melanoma highlights through an Australian lens | 63 min
1684
students
0
Free
In this lively case-study based panel discussion, our multidisciplinary experts discuss the hot topics in melanoma from ESMO 2020 including the latest research in...
Free
Melanoma near misses: Clues to diagnosis | 51 min
1710
students
0
Free
Accurately determining whether a pigmented skin lesion is benign or malignant is essential for optimal patient care. The majority of lesions can be definitely...
Free